Infeccão pelo vírus linfotrópico de células T humanas e transmissão vertical em gestantes de estado da Região Centro-Oeste do Brasil

Figueiró-Filho, Ernesto Antonio; Lopes, Alessandro Henrique Antunes; Senefonte, Flávio Renato de Almeida; Souza Júnior, Virgilio Goncalves de; Botelho, Carlos Augusto; Duarte, Geraldo.
Rev. bras. ginecol. obstet ; 27(12): 719-725, dez. 2005. tab
Artigo em Português | LILACS | ID: lil-429418

Documentos relacionados

  1. Interpretation of low reactivity in the Abbott Architect rHTLV I/II assay.
  2. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
  3. Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy.
  4. Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T-cell leukaemia virus type-1 and type-2 infection in a London teaching hospital with a large solid organ transplant centre.
  5. Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?
  6. Development of a nested real time PCR/high resolution melting assay for human T-cell lymphotropic viruses types 1 and 2 (HTLV-1 and 2) identification.
  7. The prevalence of human T-cell leukemia virus in blood donors in China.
  8. Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations.
  9. [Prevalence of Human T-Cell Lymphotropic Virus Type 1 and 2 among Blood Donors in Jiangsu from 2016 to 2019].
  10. Decline in human T-cell lymphotropic virus seroprevalence in blood donors from Minas Gerais, Brazil over a 12-year period (2006-2017).